Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant
- 15 July 1987
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 40 (1) , 7-11
- https://doi.org/10.1002/ijc.2910400103
Abstract
Lymphocytes immune to a highly immunogenic (“xenogenized”) variant of a murine lymphoma—which were shown to exert anti‐xenogenized tumor activity in a previously described model of tumor immunotherapy—were tested in the present study for possible suppressive effects on the growth of an i.c. graft of the original lymphoma. Remarkable tumor‐inhibitory effects followed the i.v. infusion of splenic lymphocytes sensitized or restimulated in vitro, or derived from animals immunized in vivo with the xenogenized tumor cells. The pattern of inhibition of the parental cells was apparently similar to that previously described for the xenogenized variant, but preliminary evidence suggests that the underlying mechanisms may be different.This publication has 19 references indexed in Scilit:
- Chemical xenogenization of tumor cellsTrends in Pharmacological Sciences, 1985
- Tum variants: immunogenic variants obtained by mutagen treatment of tumor cellsImmunology Today, 1985
- Antilymphoma graft responses in the mouse brain: A study oft‐dependent functionsInternational Journal of Cancer, 1983
- Allogeneic tumor rejection induced by the intravenous injection of Lyt-2+ cytolytic T lymphocyte clones.The Journal of Experimental Medicine, 1982
- Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.The Journal of Experimental Medicine, 1981
- Preparative nonlytic separation of Lyt2+ and Lyt2− T lymphocytes, functional analyses of the separated cells and demonstration of synergy in graft‐vs.‐host reaction of Lyt2+ and Lyt2− cellsEuropean Journal of Immunology, 1981
- Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.Proceedings of the National Academy of Sciences, 1977
- Cellular immune response to a drug-treated L5178Y lymphoma sublineNature, 1974
- REJECTION OF MARROW ALLOGRAFTSTransplantation, 1972
- IMMUNOLOGICAL ALTERNATION OF LEUKEMIC CELLS In Vivo AFTER TREATMENT WITH AN ANTITUMOR DRUGProceedings of the National Academy of Sciences, 1970